CVS Health reports Q2 2026 adjusted EPS of $2.58 versus estimate of $1.85, revenue of $106.1B versus $99.97B estimate, and raises full-year 2026 guidance to $7.90–$8.10 adjusted EPS.
FirstSquawk08/05, 05:35 PM
Related assets
Coming up for CVS
Explore next
Latest CVS news
Finnhub08/17, 04:04 PM
Jin1008/14, 09:42 PM
FirstSquawk08/06, 03:06 PM
CVS profit outlook disappoints despite strong quarterly results, causing share price decline.